Predicting Tumor Regrowth in Patients Undergoing Non-Operative Management after Total Neoadjuvant Therapy.

J Gastrointest Cancer · 2025 · PMC12583335 · PMID 41182514

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

As younger patients in our cohort had a marginally higher incidence of regrowth, early onset LARC could be considered a potential predictor of regrowth, although this association did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.